Nitric oxide and cell survival: Megakaryocytes say "NO"

Journal of Laboratory and Clinical Medicine

Volumn 137, Issue 4, 2001, Pages 225-230

  Selleri, Carmine ^a,b   Maciejewski, Jaroslaw P ^a,b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0035071832     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1067/mlc.2001.113660     Document Type: Article

References (58)

1. Nitric oxide synthases: Roles, tolls, and controls
2. The role of nitric oxide in innate immunity
3. Role of nitric oxide synthesis in macrophage antimicrobial activity
4. Nitric oxide: Physiology, pathophysiology and pharmacology
5. Effect of nitric oxide on megacaryocyte growth induced by thrombopoietin
6. Chemical biology of nitric oxide: Insights into regulatory, cytotoxic, and cytoprotective mechanism of nitric oxide
7. Molecular biology of nitric oxide synthases
8. Continuous nitric oxide synthesis by inducible nitric oxide synthase in normal human airway epithelium in vivo
9. Nitric oxide synthases: Which, where, how, and why?
10. Inducible nitric oxide synthase: What difference does it makes?
11. Biochemical aspects of the reaction of hemoglobin and NO: Implications for Hb-based blood substitutes
12. Nitric oxide and macrophage function
13. The induction of nitric oxide by interleukin-12 and tumor necrosis factor in human natural killer cells: Relationship with the regulation of lyric activity
14. Early myeloid cells are high producers of nitric oxide upon CD40 plus IFN-gamma stimulation through a mechanism dependent on endogenous TNF-alpha and IL-1-alpha
15. Interleukin 18: A pleiotropic participant in chronic inflammation
16. Induction of nitric oxide synthase is involved in the mechanism of Fas-mediated apoptosis in haemopoietic cells
17. Nitric oxide suppression of human hematopoiesis in vitro. Contribution to inhibitory action of interferon-gamma and tumor necrosis factor-alpha
18. Hematopoietic inhibition by interferon-γ is partially mediated through interferon regulatory factor-1
19. Recent advances towards understanding redox mechanisms in the activation of nuclear factor kappaB
20. Modulation of autoimmune diseases by nitric oxide
21. Free radicals, antioxidants, and the immune system
22. Role of reactive oxygen and nitrogen species in etiopathogenesis of rheumatoid arthritis
23. Nitric oxide mediation of active immunosuppression associated with graft-versus-host reaction
24. Caspase activation is required for nitric oxide-mediated, CD95(APO-1/Fas)-dependent and independent apoptosis in human neoplastic lymphoid cells
25. Fas-induced caspase denitrosylation
26. Interplay between NO and (Fe-S) clusters: Relevance to biological systems
27. Nitric oxide and mitochondrial respiration
28. Nitric oxide inhibition of cytochrome oxidase and mitochondrial respiration: Implications for inflammatory, neurodegenerative and ischaemic pathologies
29. Nitric oxide and peroxynitrite exert distinct effects on mitochondrial respiration which are differentially blocked by glutathione or glucose
30. Nitric oxide sensitivity of the aconitases
31. Nitric oxide, cytochrome c and mitochondria
32. Mitochondrial control of apoptosis
33. Mitochondrial permeability transition is a central coordinating event of apoptosis
34. Cytochrome c and dATP-dependent formation of Apaf 3/caspase 9 complex initiates an apoptotic protease cascade
35. Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9
36. Poly (ADP-ribose) polymerase, nitric oxide and cell death
37. Nitric oxide-induced apoptosis: p53-dependent and p53-independent signalling pathways
38. Genetic determinants of p53-induced apoptosis and growth arrest
39. Bcl-2 protects cells from cytokine-induced nitric oxide-dependent apoptosis
40. Bcl-2 protects macro-phages from nitric oxide-induced apoptosis
41. p53 inhibits hypoxia-inducible factor-stimulated transcription
42. P53 and vascular endothelial growth factor regulate tumor growth of NOS2-expressing human carcinoma cells
43. Activation of the cell death program by nitric oxide involves inhibition of the proteasome
44. Nitric oxide inhibits APO-1/Fas-mediated cell death
45. Mechanisms involved in the pro- and anti-apoptotic role of NO in human leukemia
46. NO: An inhibitor of cell death
47. Splenic B lymphocyte programmed cell death is prevented by nitric oxide release through mechanisms involving sustained bcl-2 levels
48. B-cell chronic lymphocytic leukemia cells express a functional inducible nitric oxide synthase displaying anti-apoptotic activity
49. + human bone marrow cells
50. Nitric oxide production and nitric oxide synthase type 2 expression by human mononuclear phagocytes: A review
51. Nitric oxide production by human monocytes. Evidence for a role of CD23
52. Requirement of the inducible nitric oxide synthase pathway for IL-1-induced osteoclastic bone resorption
53. Production of nitric oxide by murine bone marrow cells: Inverse correlation with cellular proliferation
54. Effect of nitric oxide production and oxygen tension on progenitor preservation in ex vivo culture
55. Nitric oxide induces apoptosis in megakaryocytic cell lines
56. Expression of inducible nitric oxide synthase (NOS) in bone marrow cells of myelodysplastic syndromes
57. Increased nitric oxide and inducible nitric oxide synthase in bone marrow of aplastic anemia
58. Possible roles of nitric oxide and redox cell signaling in metal-induced toxicity and carcino-genesis: A review